| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 10/17/2001 | EP0873110A4 Improved hemostatic composition for treating gingival area |
| 10/17/2001 | CN1317328A Medicine for stomatitis |
| 10/17/2001 | CN1317319A Ointment for treating bone injury and its preparing process |
| 10/17/2001 | CN1072950C Traditional Chinese medicinal powder for treating oral diseases, and method for preparing same |
| 10/17/2001 | CN1072949C Medicine for treating anorexia |
| 10/17/2001 | CN1072947C Medicine for curing waist sprain and contusion |
| 10/17/2001 | CN1072946C Diabetes treating medicine |
| 10/17/2001 | CN1072945C Medicine for curing psychosis and prepn. process thereof |
| 10/17/2001 | CN1072940C Oral liquid for anti-cancer and its prepn. method |
| 10/17/2001 | CN1072938C Traditional chinese medicine for curing gastric disease |
| 10/16/2001 | US6303651 Synergistic antioxidant veterinary compositions |
| 10/16/2001 | US6303156 Noninvasive method for increasing or decreasing the body temperature of a patient |
| 10/16/2001 | US6303155 Administering single daily dose of phosphate in the evening or at night, prior to bedtime, to cause circadian rhythm of parathyroid hormone levels which peaks during the night, whereby circadian rhythm of parathyroid level is restored |
| 10/11/2001 | WO2001074410A1 Calcium phosphate artificial bone as osteoconductive and biodegradable bone substitute material |
| 10/11/2001 | WO2001074370A1 Use of feracryl for the treatment of peptic/duodenal ulcer and/or cholera |
| 10/11/2001 | WO2001074369A1 Divided dose therapies with vascular damaging activity |
| 10/11/2001 | WO2001074368A1 Combination therapies with vascular damaging activity |
| 10/11/2001 | WO2001074346A2 Sensitization of cells to cytotoxic agents using oligonucleotides directed to nucleotide excision repair or transcritpion coupled repair genes |
| 10/11/2001 | WO2001074317A1 Methods of modulating hair growth |
| 10/11/2001 | WO2001074296A2 Treatment of non-solid mammalian tumors with vascular endothelial growth factor receptor antagonists |
| 10/11/2001 | WO2001074164A1 Methods of modulating hair growth |
| 10/11/2001 | WO2001066139A8 Use of a compound that selectively binds to cd123 to impair hematologic cancer progenitor cell |
| 10/11/2001 | WO2001028556A3 Compositions for prevention and treatment of cold and influenza-like symptoms and their methods of use |
| 10/11/2001 | WO2001024763A3 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 10/11/2001 | US20010029269 Non-steroidal antiinflammatory agent |
| 10/11/2001 | US20010029020 In vitro determination of metastatic stomach, esophageal, and colorectal cancer from sampling cells outside of the colorectal track for gene transcript or protein |
| 10/11/2001 | US20010029019 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 10/11/2001 | US20010028893 Pressurization |
| 10/11/2001 | CA2405549A1 Sensitization of cells to cytotoxic agents using oligonucleotides directed to nucleotide excision repair or transcription coupled repair genes |
| 10/11/2001 | CA2404040A1 Treatment of non-solid mammalian tumors with vascular endothelial growth factor receptor antagonists |
| 10/11/2001 | CA2402539A1 Combination therapies with vascular damaging activity |
| 10/11/2001 | CA2402078A1 Divided dose therapies with vascular damaging activity |
| 10/11/2001 | CA2401112A1 Use of feracryl for the treatment of peptic/duodenal ulcer and/or cholera |
| 10/10/2001 | EP1142578A1 Method for producing an antitumoral agent and antitumoral agent thus obtained |
| 10/10/2001 | EP1140971A1 Antisense modulation of novel anti-apoptotic bcl-2-related proteins |
| 10/10/2001 | EP1140290A2 Synergistic tumorcidal response induced by histamine |
| 10/10/2001 | EP1140194A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combined treatment of neoplasia |
| 10/10/2001 | EP1140193A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 10/10/2001 | EP1140192A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia |
| 10/10/2001 | EP1140183A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 10/10/2001 | EP1140182A2 Use of a matrix metalloproteinase inhibitor together with an antineoplastic agent, optionally also together with radiation, in the treatment of neoplasia |
| 10/10/2001 | EP1140181A1 Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia |
| 10/10/2001 | EP1140179A2 Use of a cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 10/10/2001 | EP1140178A2 Use of a matrix metallaproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 10/10/2001 | EP1140177A2 Use of an integrin antagonist and radiation in the treatment of neoplasia |
| 10/10/2001 | EP1140126A1 A nascent gold based herbal composition |
| 10/10/2001 | EP1140053A1 Composition and method for enhancing male fertility and libido |
| 10/10/2001 | EP1140050A2 A composition useful to treat periodontal disease |
| 10/10/2001 | EP1140035A1 Method for preparing an effervescent granulate comprising iron gluconate, granulate thus obtained and tablets containing the same |
| 10/10/2001 | EP1140013A1 Foaming antacid suspension tablets |
| 10/10/2001 | EP1139996A1 Deodorizing cosmetic agents |
| 10/10/2001 | EP1139762A1 Hydrogen peroxide disinfectant with increased activity |
| 10/10/2001 | EP1139746A1 Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs |
| 10/10/2001 | CN1316903A Compositions and methods for treating and preventing bone diseases using tocotrienols |
| 10/10/2001 | CN1316251A Capsule for treating nasosimusitis |
| 10/10/2001 | CN1316248A Nursing liquid for oral cavity of baby |
| 10/10/2001 | CN1072610C Drinking-water iodine-adding method and device |
| 10/10/2001 | CN1072500C Medicine for treatment of arthritis and its preparing process |
| 10/10/2001 | CN1072499C External-use medicine for curing body surface chronic ulcers |
| 10/10/2001 | CN1072497C Medicine for curing hemiplegia and its making method |
| 10/10/2001 | CN1072480C Idone-adding tooth paste and its making method |
| 10/09/2001 | US6300322 Water solution with hydroxyethyl starch, sodium ion, chloride ion, potassium iion and calcium ion for plasma substitution |
| 10/09/2001 | US6299908 Compound and method for minimizing the appearance of cutaneous neoplasms and discolorations |
| 10/09/2001 | US6299886 Treating allergy comprising administering formulation comprising potassium gluconate, magnesium oxide, pyridoxine hydrochloride, pantothenic acid, ascorbic acid and an n-3 or n-6 essential fatty acid |
| 10/09/2001 | US6299865 Selecting area of skin; applying alkaline phosphatase inhibitor other than cromoglycate or its salt to reduce hair growth |
| 10/04/2001 | WO2001073133A1 Compositions and methods for identifying and targeting cancer cells |
| 10/04/2001 | WO2001073132A1 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 10/04/2001 | WO2001073131A1 High specificity marker detection |
| 10/04/2001 | WO2001072341A2 Methods of treating neoplasia with combinations of target cell-specific adenovirus, chemotherapy and radiation |
| 10/04/2001 | WO2001072313A1 Polyphosphate for use in promoting wound healing and scar abatement |
| 10/04/2001 | WO2001072311A1 Inhibition of a novel calcium injury current that forms in neurons during injury prevents neuronal cell death |
| 10/04/2001 | WO2001072310A1 Pharmaceutical gel composition |
| 10/04/2001 | WO2001072279A2 Medical emulsion for lubrication and delivery of drugs |
| 10/04/2001 | WO2001072275A1 Oxidative fluorinator compounds as antimicrobials |
| 10/04/2001 | WO2001072144A1 Use of polyphosphate as a tooth erosion inhibitor in acidic compositions |
| 10/04/2001 | WO2000051632A3 COPPER AGONIST THAT BINDS ON THE COPPER BINDING SITE OF APP AND/OR EXERTS AN INHIBITING EFFECT ON THE RELEASE OF AMYLOID Aβ PEPTIDE |
| 10/04/2001 | US20010027216 Method for preventing hormone induced adverse effects |
| 10/04/2001 | EP1138331A2 Stool marker |
| 10/04/2001 | EP1138314A2 Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues |
| 10/04/2001 | EP1137420A1 Method for obtaining and using a combination of a purine and a nitrogen monoxide donor for preventing or treating sexual dysfunction |
| 10/04/2001 | EP1137419A1 Uses of 1-amino-3-(n,n-dimethylamino)-propylidene-1,1-bisphosphonic acid |
| 10/04/2001 | EP1137393A2 Deodorant cosmetic composition |
| 10/04/2001 | EP1137341A1 Baby food stimulating growth of the thymus |
| 10/04/2001 | EP0912095B1 Phosphate composition and its utilization |
| 10/04/2001 | CA2404432A1 Compositions and methods for identifying and targeting cancer cells |
| 10/04/2001 | CA2404428A1 High specificity marker detection |
| 10/04/2001 | CA2404157A1 Inhibition of a novel calcium injury current that forms in neurons during injury prevents neuronal cell death |
| 10/04/2001 | CA2404060A1 Methods of treating neoplasia with combinations of target cell-specific adenovirus, chemotherapy and radiation |
| 10/03/2001 | CN1315851A Oral care compositions |
| 10/03/2001 | CN1315202A Ointment for treating psoriasis |
| 10/03/2001 | CN1315201A Ointment for treating acne |
| 10/03/2001 | CN1315197A Medicine for female acyesis |
| 10/02/2001 | US6297286 Administering single enantiomer (-) tramadol or a metabolite for nausea, vomiting, dizziness, blurred vision, drowsiness, somnolence, hallucinations, respiratory depression, constipation and euphoria. |
| 10/02/2001 | US6297212 Regeneration of involuted thymus and injection into target for treatment of autoimmune diseases |
| 10/02/2001 | US6296881 Bactericide containing iron ions |
| 10/02/2001 | US6296880 To cleanse skin and facilitate the prevention, treatment, and management of skin conditions |
| 09/27/2001 | WO2001070755A1 Methods of synthesis and use of radiolabelled platinum chemotherapeutic agents |
| 09/27/2001 | WO2001070390A1 Production of magnesium supermag complexes |
| 09/27/2001 | WO2001070320A1 Methods and systems for enhancing fluid flow through an obstructed vascular site |
| 09/27/2001 | WO2001070242A2 Compositions containing molecular iodine |